Refractory Metastatic Microsatellite Stable Colorectal Cancer (MSS-CRC)
1 clinical trials · Condition
◉ Watch Refractory Metastatic Microsatellite Stable Colorectal Cancer (MSS-CRC)
| Record | Firm | Date |
|---|---|---|
| Phase 2 Study of SR-8541A in Combination With Botensilimab and Balstilimab in Subjects With Refractory Metastatic Microsatellite Stable Colorectal Cancer (MSS-CRC) (NCT06589440) | Stingray Therapeutics | 2024-11-20 |
Track Refractory Metastatic Microsatellite Stable Colorectal Cancer (MSS-CRC) automatically
Every clearance here is in the API, with alerts when new ones post.